Up-down Sequential Allocation Study to Determine the Optimal Volume, Rate, and Interval of Bolus of Ropivacaine 0.2% in Interscalene Continuous Nerve Catheters for Shoulder Surgery
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Ropivacaine (Primary)
- Indications Pain
- Focus Pharmacodynamics
- 29 Jan 2018 Planned End Date changed from 1 Nov 2019 to 1 Nov 2018.
- 29 Jan 2018 Status changed from not yet recruiting to recruiting.
- 02 Nov 2016 New trial record